What This Category Covers
This collection focuses on incretin and metabolic research pathways, including GLP-1 receptor agonism, dual GIP/GLP-1 receptor activation, triple agonism, amylin signaling, and lipolysis-focused peptide fragments.
Australia Research Peptides
Explore GLP-1, GIP, glucagon, amylin, and growth-hormone-fragment research compounds for metabolic pathway investigation. Every product is supplied strictly for laboratory research use and backed by batch-level quality documentation.
Semaglutide
GLP-1 Receptor Agonist (Ozempic analogue)
GLP-1 receptor agonist for metabolic and appetite regulation research.
2 sizes available
Tirzepatide
Dual GIP/GLP-1 Receptor Agonist (Mounjaro analogue)
Dual GIP/GLP-1 receptor agonist for advanced metabolic research.
3 sizes available
Retatrutide
Triple Agonist (GLP-1/GIP/Glucagon)
Triple incretin agonist for advanced metabolic pathway research.
2 sizes available
Cagrisema
Cagrilintide + Semaglutide Blend
Amylin analogue + GLP-1 agonist blend for dual-pathway metabolic research.
Liraglutide
GLP-1 Analogue (Saxenda/Victoza analogue)
First-generation GLP-1 analogue for established metabolic research protocols.
2 sizes available
AOD-9604
Fragment 177-191 (hGH Fragment)
Modified growth hormone fragment for lipolysis and fat metabolism research.
This collection focuses on incretin and metabolic research pathways, including GLP-1 receptor agonism, dual GIP/GLP-1 receptor activation, triple agonism, amylin signaling, and lipolysis-focused peptide fragments.
Prioritize HPLC purity analysis, mass spectrometry identity confirmation, endotoxin screening, batch traceability, and clear storage guidance before selecting any metabolic research compound.
Start with our GLP-1 comparison guide, peptide storage guide, and COA explainer before comparing compounds in this category.
All weight loss products are sold strictly for laboratory research use. Review batch documentation, storage guidance, and our Research hub before selecting compounds for controlled research protocols.